Company Data
Design Therapeutics Inc.
Ticker
DSGN
Current Price
$13.12 4.88%
Market Cap
$809.1M
Price Target
Refer to Report
Volume
302.6K
52wk Range
$3.105 - $12.98
Overview
Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.